Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
New Data Supports Prevail DCB's Safety and Efficacy
Author(s): Matthias Götberg Added: 2 weeks ago
Prof Matthias Götberg (Interventional Cardiologist at Skane University Hospital, Lund, SE) provides an overview of the recent two-year data presented from the SCAAR registry and an overview of the bifurcation subset analysis that was presented at EuroPCR in May 2025.Prof Götberg is a contributor to The Swedish Coronary Angiography and Angioplasty Registry (SCAAR), he discusses the key findings… View more

Intervention
Occlutech PFO Closure Device: A Long-Term Review
Author(s): Daniela Trabattoni Added: 1 year ago
A single centre, prospective, non-randomised study from DrDaniela Trabattoni (Monzino Cardiology Centre,Milan, IT) following device implantation of the Occlutech PFO Closure device in 442 consecutive patients.The study is particularly interesting due to the scarcity of data available on the long term follow up (over 5 years after) of device implantation. Also, the results are focussed not only… View more

Intervention
TCT 25: Short-Term Anticoagulation Vs DAPT for Preventing Device Thrombosis Following LAAC
Author(s): Josep Rodés-Cabau Added: 1 week ago
TCT 2025 - Short-term anticoagulation reduced adverse events following left atrial appendage closure (LAAC) compared to dual antiplatelet therapy (DAPT).Dr Josep Rodés-Cabau (Quebec Heart and Lung Institute, Quebec, CA) joins us at TCT 2025 to discuss findings from ANDES trial (NCT03568890) investigating the safety and efficacy of short-term anticoagulation versus DAPT for preventing device… View more

Anticoagulation

Imaging & Diagnostics
TCT 25: ENCIRCLE Trial Insights with Dr Daniels & Dr Hamid
Author(s): Nadira Hamid , David V Daniels Added: 1 week ago
TCT 2025 – Dr Nadira Hamid (Minneapolis Heart Institute, US), interventional echocardiographer sits down with ENCIRCLE's (Edwards Lifesciences) Principal Investigator, Dr David V Daniels (California Pacific Medical Center, US) to have a deep dive into the latest data with SAPIEN M3.The ENCIRCLE trial (NCT04153292) is a prospective, multicentre, single-arm study evaluating the safety and… View more

Intervention
TCT 25: PASCAL Precision System in Complex Degenerative MR
Author(s): P Kasi Ramanathan Added: 1 week ago
TCT 2025 - Sub-anlysis findings showed positive safety and efficacy outcomes of the PASCAL Precision system in degenerative mitral regurgitation (DMR) patients.Dr P Kasi Ramanathan (Promedica Toledo Hospital, US) joins us on-site at TCT 2025 to share the findings from a sub-analysis looking at the affect of implant location and leaflet lesion location on the safety and effectiveness of the PASCAL… View more

Intervention
TCT 25: VICTORY Trial: Intravascular Lithotripsy vs Super-High-Pressure Balloons for Calcified Coronary Lesions
Author(s): Matthias Bossard Added: 1 week ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus… View more

Intervention

MI/ACS
Robert M Wachter
Research Area(s) / Expertise:
Robert M Wachter is Professor and Chair of the Department of Medicine at UCSF and a leading figure in hospital medicine, having coined the term “hospitalist” in 1996. He is the author of six books, including the New York Times bestseller The Digital Doctor, with his latest, A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future, forthcoming from Portfolio/Penguin in… View more
ISET 25: FORWARD PAD IDE
Author(s): Daniel Clair Added: 8 months ago
ISET 2025 - Safety and efficacy outcomes of an intravascular lithotripsy (IVL) catheter used for the treatment of moderate to severely calcified lesions show a high ability to deliver the catheter with access to the lesion and very low rates of myocardial infarction and distal embolisation.Dr Daniel Clair (Vanderbilt University Medical Center, TN, US) joins us to discuss the key findings from the… View more

Intervention
CRT 25: AGENT IDE: 2Y Outcomes
Author(s): Jeffrey W Moses Added: 8 months ago
CRT 25 - Safety and effectiveness outcomes of the Agent drug-coated balloon (DCB) for the treatment of in-stent restenosis show a major reduction in target lesion failure, including cardiac death, myocardial infarction and target lesion revascularization, compared to balloon angioplasty. The Agent DCB also caused a significant reduction in all target lesion events in comparison with the control… View more

Intervention

Vascular Disease and Surgery
Revolutionising Thrombosis Treatment in ACS, SSP and AF: Bridging the Gaps With Next Generation Anticoagulation Strategies
Author(s): Jeffrey Weitz , Carolyn Lam , Davide Capodanno , et al Added: 2 months ago
Presented at the European Society of Cardiology (ESC) Congress 2025, Prof Carolyn Lam (Singapore, UK), Prof Davide Capodanno (Catania, IT), Dr Sneha Shah Jain (Stanford, US) and Prof Jeffrey Weitz (Hamilton, CA) examine the prevalence and challenges of stroke prevention in atrial fibrillation (AF) and after acute coronary syndrome (ACS). The faculty review current treatment guidelines, explore… View more

Anticoagulation

Electrophysiology & Arrhythmia